Name | Maryhill Manor |
---|---|
Location | 501 Madison Ave, Niagara, Wisconsin |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 66 |
Occupancy Rate | 76.97% |
Medicare ID (CCN) | 525467 |
Legal Business Name | Maryhill Manor Inc |
Ownership Type | Non Profit - Church Related |
NPI Number | 1336143726 |
Organization Name | MARYHILL MANOR INC |
Address | 501 Madison Avenue, Niagara, WI 54151 |
Phone Number | 715-251-3172 |
News Archive
Optimer Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for fidaxomicin for the treatment of Clostridium difficile infection (CDI) and for reducing the risk of recurrence when used for treatment of initial CDI.
CANCER RESEARCH UK scientists have discovered that gut stem cells replace each other in a 'one in, one out' system, which is completely different to previously accepted theories.
Emergin, a Philips Healthcare company, announced today the availability of an interface between the Emergin alert management platform and the Voalte communication server to deliver alert message notifications from Emergin to the Apple iPhone and iPod Touch devices. This integration facilitates the orchestration of voice, alert, and text communications by leveraging the flexibility of the Apple platform.
Enhanced cardiac rehabilitation (CR) programs that include a year of group or personal lifestyle and fitness coaching did not improve cardiovascular risk scores more than a standard 3-month program in patients recovering from a heart attack.
Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer (SCLC) did not improve their survival but did increase their risk of blood clots, according to a new study published online July 16 in the Journal of the National Cancer Institute.
› Verified 2 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Optimer Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for fidaxomicin for the treatment of Clostridium difficile infection (CDI) and for reducing the risk of recurrence when used for treatment of initial CDI.
CANCER RESEARCH UK scientists have discovered that gut stem cells replace each other in a 'one in, one out' system, which is completely different to previously accepted theories.
Emergin, a Philips Healthcare company, announced today the availability of an interface between the Emergin alert management platform and the Voalte communication server to deliver alert message notifications from Emergin to the Apple iPhone and iPod Touch devices. This integration facilitates the orchestration of voice, alert, and text communications by leveraging the flexibility of the Apple platform.
Enhanced cardiac rehabilitation (CR) programs that include a year of group or personal lifestyle and fitness coaching did not improve cardiovascular risk scores more than a standard 3-month program in patients recovering from a heart attack.
Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer (SCLC) did not improve their survival but did increase their risk of blood clots, according to a new study published online July 16 in the Journal of the National Cancer Institute.
› Verified 2 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 12.64 | 14.46 |
Percentage of long-stay residents who lose too much weight | 7.02 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 63.64 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.47 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.34 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 2.23 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 4.37 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 3.91 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.04 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 21.69 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 12.57 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 6.08 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 91.33 | 95.98 |
Percentage of short-stay residents who made improvements in function | 83.55 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 96.22 | 82.93 |
News Archive
Optimer Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the Company's New Drug Application (NDA) for fidaxomicin for the treatment of Clostridium difficile infection (CDI) and for reducing the risk of recurrence when used for treatment of initial CDI.
CANCER RESEARCH UK scientists have discovered that gut stem cells replace each other in a 'one in, one out' system, which is completely different to previously accepted theories.
Emergin, a Philips Healthcare company, announced today the availability of an interface between the Emergin alert management platform and the Voalte communication server to deliver alert message notifications from Emergin to the Apple iPhone and iPod Touch devices. This integration facilitates the orchestration of voice, alert, and text communications by leveraging the flexibility of the Apple platform.
Enhanced cardiac rehabilitation (CR) programs that include a year of group or personal lifestyle and fitness coaching did not improve cardiovascular risk scores more than a standard 3-month program in patients recovering from a heart attack.
Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer (SCLC) did not improve their survival but did increase their risk of blood clots, according to a new study published online July 16 in the Journal of the National Cancer Institute.
› Verified 2 days ago